Please login to the form below

Not currently logged in
Email:
Password:

Fleishman-Hillard appoints Anne de Schweinitz to lead healthcare group

She replaces Michael Rinaldo and will relocate from the US to London

Fleishman-Hillard has appointed Anne de Schweinitz as senior vice president, senior partner and managing director of healthcare, and replace Michael Rinaldo, who recently left.

De Schweinitz has over 15-years experience in the healthcare industry will relocate from New York to Fleishman-Hillard's London office and will report directly to John Saunders, president of the agency's Europe/Middle East/Africa regions.

Commenting on her appointment Saunders said: “In addition to her exceptional business development track record and her skill in leveraging the resources of our agency network, Anne understands the importance of establishing sustainable and value-based relationships with clients, while cultivating the people-centric culture that sets Fleishman-Hillard apart.”

In her new role, de Schweinitz will also work closely with Nancy Seliger, executive vice president of global client relations, to help define and shape the firm's global healthcare group, establish thought-leadership initiatives, develop emerging growth opportunities and attract new marquee talent across all of Fleishman-Hillard's local and regional healthcare teams.

Before joining Fleishman-Hillard in 2011, de Schweinitz held leadership positions at Hill & Knowlton, Manning Selvage & Lee and Big Arrow Group – assignments that took her from San Francisco to London to New York.

She also spent several years handling communications duties for the University of California, San Francisco Medical Center.

8th May 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Publicis Resolute

Publicis Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team with a...

Latest intelligence

Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...

Infographics